These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38236916)

  • 21. Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients.
    Chiaramonte MG; Frank FM; Furer GM; Taranto NJ; Margni RA; Malchiodi EL
    Acta Trop; 1999 Apr; 72(3):295-308. PubMed ID: 10232785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
    Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
    Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
    Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended screening of Trypanosoma cruzi among the offspring of infected women. Barcelona North metropolitan area, Catalonia (Spain), 2005-2016.
    Alcántara Román A; Valerio Sallent L; Pérez Quílez O; Roure Díez S; Moreno Millán N; Villanova Sanfeliu X; Martinez Cuevas O
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):397-402. PubMed ID: 28689672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-F2/3 antibodies as cure marker in children with congenital Trypanosoma cruzi infection].
    Altcheh J; Corral R; Biancardi MA; Freilij H
    Medicina (B Aires); 2003; 63(1):37-40. PubMed ID: 12673959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
    Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
    Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.
    Abras A; Muñoz C; Ballart C; Berenguer P; Llovet T; Herrero M; Tebar S; Pinazo MJ; Posada E; Martí C; Fumadó V; Bosch J; Coll O; Juncosa T; Ginovart G; Armengol J; Gascón J; Portús M; Gállego M
    J Clin Microbiol; 2017 May; 55(5):1396-1407. PubMed ID: 28202792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease.
    Brenière SF; Bosseno MF; Noireau F; Yacsik N; Liegeard P; Aznar C; Hontebeyrie M
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):289-95. PubMed ID: 12048553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.
    Fabbro DL; Danesi E; Olivera V; Codebó MO; Denner S; Heredia C; Streiger M; Sosa-Estani S
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3312. PubMed ID: 25411847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Implementation and evaluation of a locally sustainable system of prenatal diagnosis to detect cases of congenital Chagas disease in endemic areas of Paraguay].
    Russomando G; Almirón M; Candia N; Franco L; Sánchez Z; de Guillen I
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():49-54. PubMed ID: 16482814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina.
    Blanco SB; Segura EL; Cura EN; Chuit R; Tulián L; Flores I; Garbarino G; Villalonga JF; Gürtler RE
    Trop Med Int Health; 2000 Apr; 5(4):293-301. PubMed ID: 10810029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR.
    Solari A; Ortíz S; Soto A; Arancibia C; Campillay R; Contreras M; Salinas P; Rojas A; Schenone H
    J Antimicrob Chemother; 2001 Oct; 48(4):515-9. PubMed ID: 11581230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
    de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
    Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children.
    Bua J; Volta BJ; Perrone AE; Scollo K; Velázquez EB; Ruiz AM; De Rissio AM; Cardoni RL
    PLoS Negl Trop Dis; 2013; 7(10):e2476. PubMed ID: 24147166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.
    Alvarez MG; Bertocchi GL; Cooley G; Albareda MC; Viotti R; Perez-Mazliah DE; Lococo B; Castro Eiro M; Laucella SA; Tarleton RL
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004657. PubMed ID: 27128444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala.
    Brum-Soares L; Cubides JC; Burgos I; Monroy C; Castillo L; González S; Viñas PA; Urrutia PP
    Rev Soc Bras Med Trop; 2016; 49(6):721-727. PubMed ID: 28001219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
    Almeida IC; Ferguson MA; Schenkman S; Travassos LR
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.
    Machado-de-Assis GF; Silva AR; Do Bem VA; Bahia MT; Martins-Filho OA; Dias JC; Albajar-Viñas P; Torres RM; Lana M
    Clin Vaccine Immunol; 2012 Aug; 19(8):1283-91. PubMed ID: 22739694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.